Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 6.09
-0.07 (-1.14%)
May 12, 2026, 4:08 PM HKT
HKG:0512 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,241 | 2,468 | 1,880 | 2,079 | 2,403 |
Depreciation & Amortization | 581.9 | 503.75 | 392.21 | 394.91 | 339.52 |
Loss (Gain) From Sale of Assets | 1.18 | 1 | 13.06 | 0.18 | 1.55 |
Asset Writedown & Restructuring Costs | 12.76 | 44.7 | 50.14 | 26.36 | 1.51 |
Loss (Gain) From Sale of Investments | 128.38 | -675.93 | -89.27 | 94.62 | -483.68 |
Loss (Gain) on Equity Investments | -76.06 | -148.72 | 25.01 | 43.79 | -113.86 |
Provision & Write-off of Bad Debts | 39.62 | 72.98 | 57.7 | -22.64 | 11.77 |
Other Operating Activities | 64.45 | 52.42 | 219.23 | 119.75 | 144.97 |
Change in Accounts Receivable | -981.12 | -444.4 | -177.52 | -514.24 | -701.65 |
Change in Inventory | -51.88 | 74.54 | -99.41 | -295.28 | -118.74 |
Change in Accounts Payable | 583.63 | -174.31 | 290.65 | -234.58 | 605.5 |
Change in Unearned Revenue | 94.88 | 135.85 | -110.66 | 154.96 | -64.09 |
Change in Other Net Operating Assets | 10.93 | -12.17 | -26.24 | -3.78 | -19.67 |
Operating Cash Flow | 1,650 | 1,898 | 2,425 | 1,843 | 2,006 |
Operating Cash Flow Growth | -13.10% | -21.73% | 31.60% | -8.13% | 37.76% |
Capital Expenditures | -726.15 | -555.78 | -487.73 | -626.22 | -471.57 |
Sale of Property, Plant & Equipment | 2.76 | 0.97 | 6.61 | 1.99 | 23.79 |
Cash Acquisitions | -321.83 | -1,179 | -176.42 | -269.22 | -245.41 |
Sale (Purchase) of Intangibles | -795.95 | -41.25 | -0.31 | -431.37 | -64.8 |
Investment in Securities | 841.55 | -180.89 | -5.17 | -639.34 | -1,200 |
Other Investing Activities | 32.12 | -41.78 | 147.27 | -395.95 | 142.42 |
Investing Cash Flow | -967.52 | -1,997 | -515.75 | -2,360 | -1,769 |
Long-Term Debt Issued | 4,345 | 4,481 | 2,370 | 3,117 | 1,981 |
Long-Term Debt Repaid | -4,228 | -3,342 | -3,451 | -2,210 | -1,621 |
Net Debt Issued (Repaid) | 116.27 | 1,139 | -1,081 | 906.49 | 359.6 |
Repurchase of Common Stock | - | - | -81.01 | -43.99 | -143.5 |
Common Dividends Paid | -910.47 | -910.47 | -496.94 | -390.45 | -390.45 |
Other Financing Activities | -157.34 | -198.26 | -230.08 | -145.05 | -158.82 |
Financing Cash Flow | -951.54 | 29.96 | -1,889 | 327 | -333.17 |
Foreign Exchange Rate Adjustments | 70.92 | 70.56 | -124.06 | -118.42 | 12.64 |
Net Cash Flow | -198.61 | 1.27 | -104.31 | -308.85 | -83.84 |
Free Cash Flow | 923.37 | 1,342 | 1,937 | 1,216 | 1,534 |
Free Cash Flow Growth | -31.21% | -30.71% | 59.25% | -20.71% | 23.03% |
Free Cash Flow Margin | 7.52% | 11.53% | 18.40% | 12.72% | 17.84% |
Free Cash Flow Per Share | 0.26 | 0.38 | 0.55 | 0.34 | 0.43 |
Cash Interest Paid | 156.37 | 180.24 | 204.36 | 137.49 | 92.96 |
Cash Income Tax Paid | 353.98 | 480.24 | 471.08 | 349.26 | 277.32 |
Levered Free Cash Flow | -47.05 | 1,754 | 1,544 | 460.64 | 1,294 |
Unlevered Free Cash Flow | 54.41 | 1,866 | 1,672 | 546.57 | 1,352 |
Change in Working Capital | -343.56 | -420.48 | -123.18 | -892.92 | -298.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.